Martin Aringer

46PUBLICATIONS
106CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityAllergyInnate immunityBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Jun 17, 2026
Belimumab induces early and sustained resolution of lupus thrombocytopenia.

|Mar 06, 2026
[Epidemiology and manifestations of Sjögren's disease].

Martin Aringer, Anne-Kathrin Tausche

|Jan 27, 2026
[Why C-reactive protein is (usually) not high in SLE].

Erik Klapproth, Martyna Hempel, Nicolai Leuchten

|Jul 09, 2025
Type I interferon limits interleukin-6 signalling in SLE through shedding interleukin-6 receptors.

Martyna Hempel, Erik Klapproth, Annika Krause

|May 27, 2025
Interleukin-6 receptor blockade leads to low fibrinogen values as part of their effects on the acute phase.

Martin Achleitner, Oliver Tiebel, Nicolai Leuchten

|May 13, 2025
The Dynamics of Antinuclear Antibody Production in Systemic Lupus Erythematosus: New Insights for New Therapies.

Martin Aringer, David S Pisetsky

Pageof 8

Frequent Collaborators

16 joint publications

Thomas Dörner

10 joint publications

Sindhu R Johnson

7 joint publications

Dimitrios T Boumpas

6 joint publications

Andrea Doria